Literature DB >> 20623318

Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.

Giulio Vistoli1, Alessandro Pedretti, Angelica Mazzolari, Bernard Testa.   

Abstract

Metabolic problems lead to numerous failures during clinical trials, and much effort is now devoted to developing in silico models predicting metabolic stability and metabolites. Such models are well known for cytochromes P450 and some transferases, whereas less has been done to predict the activity of human hydrolases. The present study was undertaken to develop a computational approach able to predict the hydrolysis of novel esters by human carboxylesterase hCES2. The study involved first a homology modeling of the hCES2 protein based on the model of hCES1 since the two proteins share a high degree of homology (congruent with 73%). A set of 40 known substrates of hCES2 was taken from the literature; the ligands were docked in both their neutral and ionized forms using GriDock, a parallel tool based on the AutoDock4.0 engine which can perform efficient and easy virtual screening analyses of large molecular databases exploiting multi-core architectures. Useful statistical models (e.g., r (2) = 0.91 for substrates in their unprotonated state) were calculated by correlating experimental pK(m) values with distance between the carbon atom of the substrate's ester group and the hydroxy function of Ser228. Additional parameters in the equations accounted for hydrophobic and electrostatic interactions between substrates and contributing residues. The negatively charged residues in the hCES2 cavity explained the preference of the enzyme for neutral substrates and, more generally, suggested that ligands which interact too strongly by ionic bonds (e.g., ACE inhibitors) cannot be good CES2 substrates because they are trapped in the cavity in unproductive modes and behave as inhibitors. The effects of protonation on substrate recognition and the contrasting behavior of substrates and products were finally investigated by MD simulations of some CES2 complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623318     DOI: 10.1007/s10822-010-9373-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  45 in total

Review 1.  Lessons learned from marketed and investigational prodrugs.

Authors:  Peter Ettmayer; Gordon L Amidon; Bernd Clement; Bernard Testa
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

2.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

Review 3.  The biochemistry of drug metabolism--an introduction: part 3. Reactions of hydrolysis and their enzymes.

Authors:  Bernard Testa; Stefanie D Krämer
Journal:  Chem Biodivers       Date:  2007-09       Impact factor: 2.408

Review 4.  Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.

Authors:  Bernard Testa
Journal:  Curr Opin Chem Biol       Date:  2009-05-25       Impact factor: 8.822

Review 5.  The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.

Authors:  Bernard Testa; Stefanie D Krämer
Journal:  Chem Biodivers       Date:  2009-05       Impact factor: 2.408

Review 6.  The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.

Authors:  Bernard Testa; Stefanie D Krämer
Journal:  Chem Biodivers       Date:  2008-11       Impact factor: 2.408

7.  Regioselectivity and quantitative structure-activity relationships for the conjugation of a series of fluoronitrobenzenes by purified glutathione S-transferase enzymes from rat and man.

Authors:  A E Soffers; J H Ploemen; M J Moonen; T Wobbes; B van Ommen; J Vervoort; P J van Bladeren; I M Rietjens
Journal:  Chem Res Toxicol       Date:  1996 Apr-May       Impact factor: 3.739

8.  Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2.

Authors:  Kosuke Nishi; Huazhang Huang; Shizuo G Kamita; In-Hae Kim; Christophe Morisseau; Bruce D Hammock
Journal:  Arch Biochem Biophys       Date:  2006-01-01       Impact factor: 4.013

9.  Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.

Authors:  Sonal P Sanghani; Sara K Quinney; Tyler B Fredenburg; Wilhelmina I Davis; Daryl J Murry; William F Bosron
Journal:  Drug Metab Dispos       Date:  2004-05       Impact factor: 3.922

10.  Molecular modeling of CPT-11 metabolism by carboxylesterases (CEs): use of pnb CE as a model.

Authors:  Monika Wierdl; Christopher L Morton; Nathan K Nguyen; Matthew R Redinbo; Philip M Potter
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

View more
  9 in total

1.  Molecular insight into substrate recognition and catalysis of Baeyer-Villiger monooxygenase MtmOIV, the key frame-modifying enzyme in the biosynthesis of anticancer agent mithramycin.

Authors:  Mary A Bosserman; Theresa Downey; Nicholas Noinaj; Susan K Buchanan; Jürgen Rohr
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

2.  CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.

Authors:  X Wang; G Wang; J Shi; J Aa; R Comas; Y Liang; H-J Zhu
Journal:  Pharmacogenomics J       Date:  2015-06-16       Impact factor: 3.550

3.  Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins.

Authors:  Roger S Holmes; Matthew W Wright; Stanley J F Laulederkind; Laura A Cox; Masakiyo Hosokawa; Teruko Imai; Shun Ishibashi; Richard Lehner; Masao Miyazaki; Everett J Perkins; Phillip M Potter; Matthew R Redinbo; Jacques Robert; Tetsuo Satoh; Tetsuro Yamashita; Bingfan Yan; Tsuyoshi Yokoi; Rudolf Zechner; Lois J Maltais
Journal:  Mamm Genome       Date:  2010-10-08       Impact factor: 2.957

4.  Investigating the Stability of Six Phenolic TMZ Ester Analogues, Incubated in the Presence of Porcine Liver Esterase and Monitored by HPLC.

Authors:  Leroy A Shervington; Oliver Ingham
Journal:  Molecules       Date:  2022-05-05       Impact factor: 4.927

Review 5.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

6.  Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.

Authors:  Da Xiao; Deshi Shi; Dongfang Yang; Benjamin Barthel; Tad H Koch; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2012-12-07       Impact factor: 5.858

Review 7.  Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches.

Authors:  Aikaterini Zisaki; Ljubisa Miskovic; Vassily Hatzimanikatis
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  Human carboxylesterases and fluorescent probes to image their activity in live cells.

Authors:  Anchal Singh; Mingze Gao; Michael W Beck
Journal:  RSC Med Chem       Date:  2021-05-18

9.  Carboxylesterase converts Amplex red to resorufin: Implications for mitochondrial H2O2 release assays.

Authors:  Satomi Miwa; Achim Treumann; Amy Bell; Giulio Vistoli; Glyn Nelson; Sam Hay; Thomas von Zglinicki
Journal:  Free Radic Biol Med       Date:  2015-11-11       Impact factor: 7.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.